Published in Cancer Weekly, July 16th, 2002
The randomized open-label, multicenter, international phase III trial will compare Velcade with high-dose dexamethasone, a commonly used therapy, to assess the efficacy and safety of Velcade in patients with multiple myeloma whose disease has progressed after one to three prior therapeutic regimens.
The phase III trial is being...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.